Results 41 to 50 of about 209,213 (308)

Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease [PDF]

open access: yes, 2015
Interstitial lung disease (ILD) is a hallmark of systemic sclerosis (SSc). Although high-resolution computed tomography (HRCT) is the gold standard to diagnose ILD, recently lung ultrasound (LUS) has emerged in SSc patients as a new promising technique ...
Amoroso, Antonio   +8 more
core   +1 more source

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

open access: yesEuropean Respiratory Review, 2019
Two antifibrotic medications (nintedanib and pirfenidone) were recommended (conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the 2015 IPF evidence-based guidelines.
Bridget F. Collins, Ganesh Raghu
doaj   +1 more source

Recent advances in understanding idiopathic pulmonary fibrosis [PDF]

open access: yes, 2016
Despite major research efforts leading to the recent approval of pirfenidone and nintedanib, the dismal prognosis of idiopathic pulmonary fibrosis (IPF) remains unchanged.
Daccord, C, Maher, TM
core   +3 more sources

Familial Interstitial Lung Disease

open access: yesSeminars in Respiratory and Critical Care Medicine, 2020
AbstractThe interstitial lung diseases (ILDs) are a group of progressive disorders characterized by chronic inflammation and/or fibrosis in the lung. While some ILDs can be linked to specific environmental causes (i.e., asbestosis, silicosis), in many individuals, no culprit exposure can be identified; these patients are deemed to have “idiopathic ...
openaire   +3 more sources

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis

open access: yesMedical Sciences, 2018
Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias.
Estrella Fernández Fabrellas   +3 more
doaj   +1 more source

In vivo compartmental analysis of leukocytes in mouse lungs [PDF]

open access: yes, 2015
The lung has a unique structure consisting of three functionally different compartments (alveolar, interstitial, and vascular) situated in an extreme proximity.
O'Dea, KP   +4 more
core   +1 more source

The therapy of idiopathic pulmonary fibrosis: what is next?

open access: yesEuropean Respiratory Review, 2019
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease, characterised by progressive scarring of the lung and associated with a high burden of disease and early death.
Vivien Somogyi   +5 more
doaj   +1 more source

YouTube-videos for patient education in lymphangioleiomyomatosis?

open access: yesRespiratory Research, 2022
Background The Internet is commonly used by patients to acquire health information. To date, no studies have evaluated the quality of information available on YouTube regarding lymphangioleiomyomatosis (LAM).
Finn M. Wilkens   +7 more
doaj   +1 more source

Imaging diagnosis-computed tomography of traction bronchiectasis secondary to pulmonary fibrosis in a Patterdale Terrier [PDF]

open access: yes, 2016
An 8-year-old, Patterdale terrier was referred for evaluation of tachypnoea, exercise intolerance, and weight loss. Computed tomographic images showed pneumomediastinum, diffuse pulmonary ground glass opacity, and marked dilatation of peripheral bronchi,
Fitzgerald, E   +2 more
core   +2 more sources

The incidence of malignancies in asbestosis with chrysotile exposure: a large Chinese prospective cohort study

open access: yesFrontiers in Oncology, 2023
BackgroundAsbestos exposure is closely related to the occurrence and development of various malignancies. This prospective cohort study aimed to evaluate the incidence rate and potential risk factors in a cohort of asbestosis patients in China.MethodsThe
Jingwei Wang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy